Pertussis Vaccines: Whole-cell & Acellular Vaccines, Different Types & Manufacturers along with the Regimen in Various Age Groups

Infectious Diseases

Moderna’s COVID-19 Vaccine; Quidel’...

Moderna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273.   The results of interim Phase I clinical trial showed promising outcomes in terms of...

May 19, 2020

Security-Breach-in-healthcare-industry
Security Breach: A Growing Concern For The Healthcare Industry

Telehealth and online medical services have accorded many opportunities for healthcare professionals and patients around the world. A larger section of society is leveraging online medical services for the treatment, diagnosis, and monitoring of diseases.  Due to Covid-19, online health services have registered ...

Find More
second-wave-of-coronavirus
Will there be a second wave of coronavirus?

The Worldwide situation due to novel coronavirus since its outbreak in china is getting worse with each passing day. To flatten the curve, countries around the world have adopted various unprecedented measures.  The shutdown and social distancing have slowed down the rate of infection to a larger extent but...

Find More
Telehealth
Telehealth: Opportunities and Hurdles in Virtual Healthcare Market

The development of telecommunications and web technologies over the past few decades has brought a revolutionary change in almost every industry. Healthcare industry is no exception to this change. Each day a new application of the internet is in use for better healthcare information and healthcare service del...

Find More

More Views & Analysis

Latest COVID-19/ SARS-CoV-2 news
In the race to fight SARS-CoV-2: Merck, ISB; ViiV; Genalyte gears up

Merck has collaborated with the Seattle-based Institute for Systems Biology (ISB) to further study novel coronavirus SARS-CoV-2. The primary goal of the collaboration will be to investigate the molecular pathway of SARS-CoV-2 and aetiology of COVID-19 with the intent of finding an effective and standard treatm...

Find More

Covid-19-diagnostic-projects
Potential Diagnostic solutions that may significantly contribute to COVID-19 detection

Novel coronavirus outbreak has created some unprecedented situations in several domains round the World. No vertical is left untouched as the economy tumbles down impacting the human race. Goals of the several industries such as tourism and hospitality that are hit hard, have shifted as they find new ways to create...

Find More

COVID-19-pipeline-development
COVID19 pipeline advances as Novartis begins phase III trial of hydroxychloroquine; and advancements in RCC, and HER2 positive breast cancer market

The U.S. FDA has given its nod to Seattle Genetics for its Tukysa (tucatinib) for advanced unresectable or metastatic HER2-positive breast cancer Genetics Tukysa (tucatinib) is a tyrosine kinase inhibitor of the HER2 protein, administered orally in combination with chemotherapy agents trastuzumab and capec...

Find More

copper against SARS-CoV-2
Novel coronavirus crumbles down as soon as it lands on copper

Research says copper disintegrates novel coronavirus – SARS-CoV-2- the moment it lands on the metal. The global coronavirus pandemic has made everyone around cautious of hygiene and cleanliness. The transmission of microbes through droplets, touching, sneezing has brought a wave face masks, 20-seconds hand wash,...

Find More

Ventilator demand amid Coronavirus crisis
Supply shortage: Why ventilators are in demand amid the Coronavirus crisis

The Novel Coronavirus since its outbreak in Wuhan China in November-2019 has infected around 1,848,439 people with 117,217 confirmed deaths in 213 countries, till date.  Countries around the world are working tirelessly to tackle the current situation. Local Governments in order to reduce the pace of corona...

Find More

covid-news
In the fight against COVID-19 – Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit

Eli Lilly has announced to begin clinical trials of rheumatoid arthritis drug Olumiant to treat COVID-19 patients.  The company plans to explore the anti-inflammatory responses that were witnessed in rheumatoid arthritis patients, and how the drug – Olumiant – an oral JAK1/JAK2 inhibitor – might help in cur...

Find More

Interoperability refers to the ability of electronic health records (EHRs) and other healthcare data.....

Find More

An inflammatory disease of large intestine, Ulcerative Colitis (UC), is approached with therapies th.....

Find More

The pharma industry has played a crucial role in fighting against the pandemic situation by supplyin.....

Find More

Dementia is one of the major chronic and progressive syndrome caused by a number of different condit.....

Find More

Primary Progressive Aphasia (PPA) is a rare neurological disorder that results from the damages to t.....

Find More

Today, the sedentary lifestyle adopted among people has led to cause a myriad of underlying diseases.....

Find More